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Abstract
 
In a depleted lymphoid compartment, naive T cells begin a slow proliferation that is indepen-
dent of cognate antigen yet requires recognition of major histocompatibility complex–bound
self-peptides. We have followed the phenotypic and functional changes that occur when naive
CD8
 
1
 
 T cells undergo this type of expansion in a lymphopenic environment. Naive T cells
undergoing homeostasis-driven proliferation convert to a phenotypic and functional state simi-
lar to that of memory T cells, yet distinct from antigen-activated effector T cells. Naive T cells
dividing in a lymphopenic host upregulate CD44, CD122 (interleukin 2 receptor 
 
b
 
) and Ly6C
expression, acquire the ability to rapidly secrete interferon 
 
g
 
, and become cytotoxic effectors
when stimulated with cognate antigen. The conversion of naive T cells to cells masquerading
as memory cells in response to a homeostatic signal does not represent an irreversible differen-
tiation. Once the cellularity of the lymphoid compartment is restored and the T cells cease
their division, they regain the functional and phenotypic characteristics of naive T cells. Thus,
homeostasis-driven proliferation provides a thymus-independent mechanism for restoration of
the naive compartment after a loss of T cells.
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Introduction
 
In the immunocompetent adult, the size and subset com-
position of the peripheral T cell pool is maintained despite
the ongoing input of naive T cells from the thymus, the ex-
pansion and subsequent death of antigen-specific T cells
during immune responses, and the graduation of T cells to
the memory compartment after antigen encounter. The
homeostatic mechanisms that control the size of the lym-
phocyte compartment remain largely a mystery (1). Evi-
dence suggests that TCR/MHC-derived signals are essen-
tial for regulating homeostasis of the naive T cell pool at
multiple stages. For example, specific interactions between
the newly rearranged TCR of immature thymocytes and
self-peptide/MHC molecules in the thymus are vital to the
selection and export of a useful T cell repertoire. In addi-
tion, MHC-bound foreign peptides are crucial to the initi-
ation of an adaptive immune response, resulting in the ex-
pansion of antigen-specific T cells and their differentiation
to effector cells. Recently, it has become clear that naive T
cells depend on self-peptide/MHC–derived signals for their
peripheral homeostasis (2). Interactions between naive T
cells and MHC molecules are important for the delivery of
survival signals once cells enter the periphery; both newly
 
generated CD8
 
1
 
 and CD4
 
1
 
 T cells die in the absence of
peripheral expression of MHC class I and II, respectively
(3–10). Furthermore, the homeostasis-driven expansion of
naive T cells, which is the proliferation of cells in a lym-
phopenic environment without cognate antigen, requires
specific TCR interactions with self-peptide/MHC (10–14).
The lymphoid system has great resiliency. After destruc-
tion of the hematopoietic system with whole body irradia-
tion, ablative chemotherapy, or viral immunodeficiency,
the peripheral T cell count can “bounce back” (15–17). In
most cases, it has not been clear whether this recovery is
due to new thymic output or to the expansion of the few
surviving peripheral T cells. In human and animal studies,
the recovery of CD4
 
1
 
 and CD8
 
1
 
 T cell numbers occurs
faster in younger compared with older individuals (18, 19).
This may indicate a more efficient thymic contribution in
young animals, or may reflect the peripheral environment.
One common finding in studies of the regenerating T cell
compartment is that most of the peripheral T cells have an
activated or memory phenotype, as defined by surface
markers such as CD44 and CD45 (15, 16). This has led to
the notion that only memory T cells have the ability to re-
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plenish the peripheral T cell pool, whereas recovery of the
naive compartment must depend on thymic output. This is
at odds with recent studies using labeled naive T cells adop-
tively transferred into lymphopenic hosts, which clearly il-
lustrate the ability of naive T cells to expand under these
conditions (10–14, 20).
Some recent reports have noted a change in the surface
phenotype of naive T cells undergoing homeostasis-driven
proliferation (11–13, 21). In our previous study of CD8
 
1
 
 T
cells, for example, we reported early upregulation of CD44
expression, but no change in other surface markers such as
CD62L, CD25, or CD49d (11). These data implied that
naive T cells undergoing homeostasis-driven proliferation
may convert to a memory or activated state. To address the
issue of whether homeostasis-driven proliferation may be
important in the regeneration of the naive T cell compart-
ment, we followed the phenotypic and functional charac-
teristics of naive CD8
 
1
 
 T cells over a time course. This in-
cluded an assessment of actively dividing cells early after
their introduction into a depleted lymphoid compartment,
as well as later, when the compartment was restored to nor-
mal numbers and the transferred cells had ceased dividing.
 
Materials and Methods
 
Mice and Cell Transfers.
 
Transgenic mice expressing OT-I
TCR have been described previously (22). The OT-I TCR uti-
lizes a V
 
a
 
2V
 
b
 
5 heterodimer to recognize a peptide derived from
OVA (OVAp) presented by H2-K
 
b
 
. OT-I TCR transgenic mice
on the C57BL/6 (B6)
 
1
 
 background were crossed to recombina-
tion activating gene (RAG)-1–deficient (RAG
 
2
 
/
 
2
 
) mice (The
Jackson Laboratory), also on the B6 background. Cells harvested
from the spleen and lymph nodes of OT-I mice were 
 
.
 
75%
V
 
a
 
2
 
1
 
V
 
b
 
5
 
1
 
CD8
 
1
 
 by flow cytometric analysis. The OT-I cells
were either transferred directly or after enrichment for CD44
 
lo
 
Ly6C
 
lo
 
 cells by depleting cells coated with biotinylated anti-
CD44 and anti-Ly6C antibodies with streptavidin-coated mag-
netic beads (Dynal). The purified cells were 
 
.
 
90% CD8
 
1
 
V
 
a
 
2
 
1
 
and 
 
,
 
1.5% CD8
 
1
 
CD44
 
hi
 
Ly6
 
hi
 
, and were injected intravenously
into unirradiated RAG
 
2
 
/
 
2
 
 hosts or into B6 mice that had been
irradiated 2 d earlier with 650 cGy.
To generate memory T cells, 3 
 
3
 
 10
 
6
 
 pooled spleen and
lymph node cells from OT-I RAG
 
2
 
/
 
2
 
 mice were transferred into
B6 hosts that had been irradiated with 400 cGy 2 d earlier. Mice
were infected 2 d after cell transfer with 5 
 
3
 
 10
 
6
 
 PFU of vaccinia
virus encoding OVA. Memory cells were used 
 
.
 
90 d later and
were detected by staining with V
 
a
 
2 and V
 
b
 
5 antibodies or with
K
 
b
 
-OVAp tetramers (a gift of S.C. Jameson, University of Min-
nesota, Minneapolis, MN). To assess in vivo proliferation, mice
were given drinking water with 5-bromo-2
 
9
 
-deoxyuridine
(BrdU) at 0.8 mg/mL made fresh daily for 7 d before the indi-
cated time point.
 
Phenotypic Characterization by Flow Cytometry.
 
Pooled spleen
and lymph node cells were stained for analysis by flow cytometry
as follows: 10
 
6
 
 cells were first blocked with unconjugated anti-
CD32/16 (2.4G2) for 5 min. Samples were then incubated with
biotinylated antibodies for 20 min, washed twice and then incu-
 
bated for 20 min with directly conjugated antibodies and strepta-
vidin-PerCP (Becton Dickinson), followed by two washes. The
following antibodies were used for flow cytometry and magnetic
bead depletion (BD PharMingen): CD8-APC (53-6.7), V
 
a
 
2-PE
and biotin (B20.1), V
 
b
 
5.1,5.2-FITC (MR9-4), CD44-biotin
(IM7), and CD122(IL2R-
 
b
 
)-PE (TM-
 
b
 
1). All samples were col-
lected on a FACSCalibur™ (Becton Dickinson), and data were
analyzed using CELLQuest™ software (Becton Dickinson).
Cells from BrdU-pulsed mice were prepared for flow cytome-
try as described previously (23). In brief, cells were surface stained
with PE-conjugated anti-V
 
a
 
2, TRI-color–conjugated (BD
PharMingen) CD8, and biotinylated anti-CD44. Next, cells were
resuspended in 0.5 ml 0.15 M NaCl, and 1.2 ml of 95% ethanol
was added dropwise while mixing. After a 30-min incubation,
cells were washed with PBS and then incubated in 1% paraform-
aldehyde with 0.01% Tween-20 for 30 min at room temperature,
followed by 30 min on ice. Cells were washed again in PBS and
then incubated for 10 min with 50 Kunitz U/ml of DNase I
(Sigma-Aldrich) in 0.15 M NaCl, 4.2 mM MgCl
 
2
 
, and 10 
 
m
 
M
HCl. Cells were centrifuged, supernatants removed, and FITC-
conjugated anti-BrdU (Becton Dickinson) and APC-conju-
gated streptavidin were added for 30 min, followed by a wash
with PBS.
 
IFN-
 
g
 
 Staining.
 
Pooled spleen and lymph node cells from
the indicated hosts were incubated at 2 
 
3
 
 10
 
6
 
 cells per well in
RP10 media (RPMI, 10% heat-inactivated FCS) alone or with
10 nM OVAp for a total of 8 h at 37
 
8
 
C. After the first 3 h of cul-
ture, 1 
 
m
 
L of Golgi Plug (BD PharMingen) was added to each
well. Cells were then harvested and stained for flow cytometric
analysis. Cells were blocked with 2.4G2 for 5 min, then stained
for surface molecules with PE-conjugated anti-V
 
a
 
2, TRI-color–
conjugated CD8, and APC-conjugated CD4. After surface stain-
ing, the cells were resuspended in 200 
 
m
 
L of Cytofix/Cytoperm
(BD PharMingen) and incubated for 20 min on ice. Samples
were washed twice with Perm/Wash (BD PharMingen). Samples
were then blocked with 2.4G2 diluted in Perm/Wash buffer for
5 min, followed by the addition of FITC-conjugated anti–IFN-
 
g
 
(BD PharMingen), and were incubated on ice for 20 min. Sam-
ples were washed twice with 1 mL of Perm/Wash and resus-
pended in 200 
 
m
 
l of Cytofix/Cytoperm.
 
CTL Assay.
 
EL4 target cells were labeled with [
 
51
 
Cr]sodium
chromate in the presence or absence of OVAp at 5 
 
m
 
M. Labeled
target cells were washed three times, and 5 
 
3
 
 10
 
3
 
 cells were placed
in wells of a round-bottomed 96-well plate. OT-I T cells under-
going homeostatic proliferation in irradiated B6 hosts and memory
OT-I cells were tested for direct ex vivo CTL killing. At the indi-
cated time points, pooled spleen and lymph node cells were as-
sayed; the percentage of V
 
a
 
2
 
1
 
V
 
b
 
5
 
1
 
CD8
 
1
 
 cells in each sample was
determined by flow cytometry and added to each well in numbers
that were normalized for the number of V
 
a
 
2
 
1
 
V
 
b
 
5
 
1
 
CD8
 
1
 
 cells.
Primary CTL effectors were established from OT-I splenocytes by
stimulation with irradiated B6 splenocytes pulsed with 1 
 
m
 
M
OVAp, and were used on days 5–7 after stimulation.
 
Results
 
To analyze the changes that occur during the homeo-
stasis-driven proliferation of naive CD8
 
1
 
 T cells, small
numbers of peripheral cells from OT-I TCR transgenic,
RAG-1
 
2
 
/
 
2
 
 donors (OT-I RAG
 
2
 
/
 
2
 
) were transferred into
sublethally irradiated B6 hosts. During the subsequent weeks,
both donor and host cells contribute to the recovery of the
 
1
 
Abbreviations used in this paper:
 
 B6, C57BL/6; RAG, recombination acti-
vating gene. 
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T cell compartment. Both donor and surviving host T cells
slowly expand, and the thymus also contributes its output
of newly differentiated T cells. In this system, lymphoid
homeostasis is eventually restored. In one series of experi-
ments, we also used nonirradiated RAG
 
2
 
/
 
2
 
 mice as hosts,
in which case the host can make no contribution to the re-
covery of lymphoid cell numbers.
 
Homeostasis-driven Proliferation of Naive T Cells Results in
Phenotypic Conversion.
 
Recent experiments with carboxy-
fluorescein diacetate-succinimidyl ester (CFSE)-labeled T
cells have shown that all or most undergo a slow prolifera-
tion when transferred into a lymphopenic host and that this
proliferation is accompanied by the upregulation of CD44
(11–13, 21). To analyze this phenotypic conversion fur-
ther, naive T cells from OT-I RAG
 
2
 
/
 
2
 
 mice were further
depleted of CD44
 
hi
 
Ly6C
 
hi
 
 cells using magnetic beads, and
were injected into sublethally irradiated syngeneic B6 hosts.
After 17 d of expansion, the phenotype of the injected na-
ive CD8
 
1
 
 T cells had changed dramatically (Fig. 1). They
uniformly upregulated CD44, Ly6C, and CD122 (IL-
2R
 
b
 
) compared with naive CD8
 
1
 
 T cells that express low
levels of all three of these markers. This surface phenotype
is similar to that of “true” memory cells activated by cog-
nate antigen in adoptive transfer and allowed to rest for
 
.
 
90 d (Fig. 1). As there is no definitive marker of memory
T cells, antigen-experienced cells have been identified by a
combination of phenotypic and functional characteristics.
A consensus has emerged in which B6 CD8
 
1
 
 memory T
cells express high levels of CD44, Ly6C, and CD122, with
high to heterogeneous expression of CD62L (24–30).
Ly6C is expressed at low, heterogeneous levels on effector
cells, and thus is useful to distinguish between CD8
 
1
 
 mem-
ory and effector T cells (Fig. 1; references 24, 30). The
CD8
 
1
 
 T cells undergoing homeostasis-driven proliferation
have a surface phenotype characteristic of memory CD8
 
1
 
T cells (Fig. 1). Furthermore, unlike effectors, the cells do
not significantly upregulate CD25, CD49d, or CD69, nor
do they downregulate CD62L or the TCR (data not
shown). Our follow-up experiments were designed to ex-
amine the kinetics and stability of the changes that occur
during and after homeostasis-driven proliferation.
 
Kinetics of Homeostasis-driven Proliferation in Lymphopenic
Hosts.
 
Naive OT-I RAG
 
2
 
/
 
2
 
 T cells were transferred into
sublethally irradiated B6 hosts, and the total numbers of
OT-I cells recovered from spleen and lymph nodes were
determined over time. Cell numbers increase dramatically
during the first 20 d, then reach a plateau (Fig. 2 A). Esti-
mates of the recovery of OT-I T cells were based on the
number of V
 
a
 
2
 
1
 
V
 
b
 
5
 
1
 
CD8
 
1
 
 cells recovered, as no clono-
typic antibody is available for the OT-I TCR. The back-
ground of V
 
a
 
2
 
1
 
V
 
b
 
5
 
1
 
CD8
 
1
 
 cells in the spleen of a normal
B6 mouse is 2
 
1
 
/
 
2
 
0.7% of the total CD8s. Also, 
 
.
 
90% of
V
 
a
 
2
 
1
 
V
 
b
 
5
 
1
 
CD8
 
1
 
 cells in the mice that received OT-I
Figure 1. Naive T cells undergoing homeostasis-driven proliferation
acquire a memory phenotype. Expression of CD44, Ly6C, and CD122
on OT-I RAG2/2 T cells transferred 17 d earlier into an irradiated B6
host compared with naive, memory, and effector OT-I RAG2/2 CD81
T cells. Histogram plots show expression of the indicated marker for
Va21Vb51CD81 gated cells. Before transfer, OT-I CD81 cells were de-
pleted of CD44hi and Ly6Chi cells. Memory cells were recovered from ir-
radiated B6 hosts that had received 3 3 106 OT-I RAG2/2 cells, fol-
lowed by infection with vaccinia virus encoding OVA .90 d earlier.
OT-I effectors were analyzed on day 5 after in vitro stimulation with
OVAp-coated, irradiated splenocyte feeder cells.
Figure 2. Kinetics of homeostasis-driven proliferation. Irradiated B6
hosts received 3 3 106 OT-I RAG2/2 T cells. (A) Total numbers of OT-I
T cells were estimated by determining the number of Va21Vb51CD81
T cells recovered from the pooled spleen and lymph nodes (four mice per
time point). At day 28 of transfer, 25%1/23.4 of recovered cells are OT-I,
6.8%1/20.5 are host-derived CD81 T cells, and 21%1/21.1 are host-
derived CD41 T cells. (B) The level of proliferation by transferred OT-I
cells was determined at each time point by BrdU incorporation. Mice
were given BrdU for 7 d before each time point (two mice per time
point). The percentage of Va21CD81 cells that had incorporated BrdU is
shown. The insets show BrdU staining for Va21CD81 gated cells 12 and
49 d after transfer.560 Regeneration of a Naive Peripheral T Cell Pool
RAG2/2 T cells stain with Kb-OVAp tetramers, indicating
that the majority of recovered Va21Vb51CD81 cells are
OT-I cells (data not shown). To determine how many of
the recovered OT-I cells were dividing, mice were pulsed
with BrdU for 7 d before each time point (Fig. 2 B). Be-
tween days 5 and 12 after transfer, the majority (80–88%)
of the OT-I cells divided. By 37 d after transfer, only 12–
15% of the OT-I cells had undergone proliferation during
the 7-d BrdU pulse. The level of incorporation at day 37
and beyond is similar to the basal levels of proliferation of
CD81 T cells in unmanipulated B6 mice (23). Thus, it ap-
pears that the proliferation rate of the transferred OT-I T
cells is low after their numbers stabilize and the lymphoid
compartment returns to normal cellularity.
Homeostasis-driven Proliferation of Naive T Cells Is Accom-
panied by a Reversible Phenotypic Conversion. By 5 d after
transfer, a significant percentage of OT-I cells has upregu-
lated CD44, Ly6C, and CD122 (data not shown), and by
days 12–20, the majority have homogenous expression of
high levels of these markers (Fig. 3). No changes are ob-
served in the expression of CD5, CD25, CD62L, CD69,
or the TCR at any of the time points (data not shown). In-
terestingly, the phenotypic conversion of naive OT-I cells
to a “memory-like” phenotype is not an irreversible differ-
entiation. Between 20 and 30 d after transfer, the OT-I
cells begin to downregulate their expression of all three ac-
tivation/memory markers (Fig. 3). By 40–50 d after trans-
fer, the majority of OT-I cells no longer express signifi-
cantly higher levels of CD44, Ly6C, or CD122 than naive
OT-I cells. Thus, the homeostasis-driven proliferation of
naive T cells is accompanied by a transient conversion of
the expanding cells to a “memory-like” phenotype, fol-
lowed by a reversion back to a naive phenotype.
OT-I Cells Undergoing Homeostasis-driven Proliferation
Transiently Acquire Ex Vivo CTL Activity and the Ability to
Make IFN-g. Naive CD81 T cells from OT-I RAG2/2
mice do not lyse targets bearing their cognate antigen when
tested directly ex vivo (Fig. 4 A), nor do they have the abil-
ity to produce IFN-g during an 8-h pulse with antigen
(Fig. 5 A). In contrast, effector cells that have recently been
stimulated with antigen display high levels of target lysis
and IFN-g production (Figs. 4 A and 5 A). OT-I memory
T cells can lyse targets ex vivo and produce IFN-g more
Figure 3. OT-I T cells revert to a naive phenotype after homeostasis-
driven proliferation. Expression levels of CD44, Ly6C, and CD122 for
Va21Vb51CD81 gated naive OT-I T cells analyzed on the same day (m)
or OT-I RAG2/2 cells recovered from two different irradiated B6 hosts
(circles) at the indicated time points are graphed. (A) Percentage of
CD44hi of Va21Vb51CD81 gated T cells. Histogram insets show CD44
expression for transferred OT-I cells at days 20, 49, and 120 (filled histo-
gram) overlayed with naive OT-I cells (open histogram). (B) Percentage
of Ly6C1 of Va21Vb51CD81 gated T cells. Histogram insets show
Ly6C expression for transferred OT-I cells at days 20, 45, and 120 (filled
histogram) overlayed with naive OT-I T cells (open histogram). (C) Ex-
pression of CD122 on naive OT-I cells (open histogram) and OT-I cells
20 and 68 d after transfer (filled histogram).
Figure 4. OT-I cells undergo-
ing homeostasis-driven prolifera-
tion transiently acquire ex vivo
CTL activity. Percentage of spe-
cific lysis of OVAp-pulsed syn-
geneic targets was determined in
a 6-h CTL assay. Lysis of target
cells in the absence of OVAp
was  ,6%. (A) Cytotoxic activity
is shown for in vitro–stimulated
OT-I effectors, in vivo–derived
memory cells, and naive OT-I
cells. (B) Cytotoxic activity is
shown for OT-I cells recovered
from spleen and lymph nodes of
irradiated B6 hosts at the indi-
cated time points after transfer.
The E/T ratios were normalized
for the number of OT-I
(Va21Vb51CD81) cells in all
samples. Fresh, naive OT-I
RAG2/2 control cells and OT-I
effector cells were run at every
time point. Naive cells never
gave lysis .10% at the highest
E/T, and effector cells always
gave lysis .60% at 11:1. CTL
activity of memory OT-I cells was assayed on four occasions and was al-
ways intermediate between naive and effector activity.561 Goldrath et al.
rapidly than naive T cells, though they are less efficient in
lysis and IFN-g production than effector cells (Figs. 4 A
and 5 A; references 25–28, 31). When the functional activ-
ity of the OT-I cells dividing in response to a homeostatic
signal is measured at day 5, no ex vivo CTL killing is ob-
served (Fig. 4 B; references 11, 13). However, between 12
and 31 d after transfer, OT-I cells exhibit significant anti-
gen-specific killing in a 6-h CTL assay (Fig. 4 B), and make
IFN-g during an 8-h stimulation with OVA peptide (Fig. 5
B). Thus, as observed with surface markers, OT-I cells un-
dergoing homeostasis-driven proliferation resemble mem-
ory cells in function. As is the case for phenotypic conver-
sion, both rapid CTL activity and IFN-g production are
transient. By day 45, the ability to perform effector func-
tions in vitro wanes, and they become similar to naive cells
(Figs. 4 B and 5 B).
OT-I T Cells Transferred into RAG2/2 Hosts Divide Indefi-
nitely and Show Phenotypic and Functional Conversion, but not
Reversion. When naive OT-I RAG2/2 T cells were trans-
ferred into RAG2/2 hosts, they proliferated and displayed
phenotypic and functional changes as described for OT-I
cells transferred into irradiated B6 hosts (Table I and Fig.
6). At 20 d after transfer into the RAG2/2 host, the OT-I
cells have upregulated CD44 and Ly6C, have ex vivo CTL
activity (Table I), and produce IFN-g after stimulation
(Fig. 6 C). Therefore, OT-I cells undergoing homeosta-
sis-driven proliferation in RAG2/2 hosts acquire a “mem-
ory-like” phenotype as they do in irradiated B6 hosts.
However, unlike the situation in B6 hosts, the OT-I cells
transferred into RAG2/2 hosts do not revert to a naive sta-
tus by either phenotypic or functional criteria at later time
points (Table I and Fig. 6). 35% of the OT-I cells trans-
ferred into RAG2/2 hosts incorporated BrdU between 61
and 68 d, compared with only 7% in B6 hosts (Table I).
Even at day 92, 47% of the OT-I cells divided during the
previous week (Fig. 6 A). Additionally, the OT-I cells in
RAG2/2 hosts maintain CTL activity and the ability to
make IFN-g 68 d after transfer, unlike cells recovered from
irradiated B6 hosts at the same time point (Fig. 6 C and Ta-
ble I). OT-I cells recovered from RAG2/2 recipients retain
the “memory-like” phenotype even 92 d after transfer, dis-
playing high levels of CD44, Ly6C, and CD122 (Fig. 6 B).
This is in marked contrast to the reversion to a naive phe-
notype by 60–90% of the OT-I cells in B6 hosts by day 37
after transfer (Fig. 3).
Why do OT-I cells continue to divide in RAG2/2
hosts? One possible explanation is that the RAG2/2 lym-
phocyte compartment is never reconstituted, so the trans-
ferred cells continue to receive a signal for homeostatic
Figure 5. OT-I cells undergoing homeostasis-driven proliferation rap-
idly make IFN-g at early time points. Pooled spleen and lymph node cells
were incubated with (bold lines) or without (dotted lines) OVAp for 8 h,
and were stained with anti–IFN-g. Histogram overlays are shown for
CD81 gated cells, as the cells cannot be stained for either Va2 or Vb5 ex-
pression because the antigen pulse induces TCR downregulation. (A)
IFN-g levels for naive, memory, and effector OT-I cells. The inset shows
tetramer staining, Kb-OVAp (bold line), or a control Kb-peptide (dotted
line), of CD81 gated memory cells before peptide stimulation. (B) IFN-g
staining for CD81 gated cells recovered from irradiated B6 hosts at the in-
dicated time points. Figure 6. Proliferation of OT-I cells in RAG2/2 recipients. (A) BrdU
incorporation is shown for Va21CD81 gated cells recovered from pooled
spleen and lymph nodes of RAG2/2 hosts given BrdU for 7 d before the
indicated time point. (B) Phenotype of Va21Vb51CD81 gated T cells
from pooled spleen and lymph nodes of naive OT-I RAG2/2 mice or
OT-I RAG2/2 cells recovered from RAG2/2 hosts at the indicated time
points. (C) IFN-g production by CD81 cells recovered from RAG2/2
hosts at the indicated time points after 8 h of stimulation with OVAp
(bold lines) or media alone (dotted lines).562 Regeneration of a Naive Peripheral T Cell Pool
proliferation. In support of this idea, the number of OT-I
cells recovered from the RAG2/2 hosts never reaches the
level achieved in B6 hosts (Table I). Thus, the RAG2/2
hosts remain lymphopenic. It is not clear why the OT-I T
cells do not accumulate in the RAG2/2 hosts. The absence
of fully developed secondary lymphoid organs or the ab-
sence of either B cells or other T cells in RAG2/2 hosts
may explain why OT-I numbers do not increase at the rate
seen in B6 hosts.
Discussion
We have observed that during homeostasis-driven pro-
liferation, naive OT-I CD81 T cells acquire surface mark-
ers and functional characteristics reminiscent of memory
cells. As the lymphoid compartment is restored to normal
cellularity because of the expansion of both donor and host
cells, the signal for homeostasis-driven proliferation wanes
and the T cells cease dividing. Remarkably, the cells that
converted to a “memory-like” phenotype revert to a naive
phenotype as homeostasis is regained. The conversion to a
“memory-like” phenotype correlates with proliferation of
the OT-I cells, and their reversion back to a naive pheno-
type correlates with a return to a resting state.
The dramatic changes in surface phenotype and function
after transfer into an irradiated host occur in the popula-
tion of OT-I T cells as a whole and are not due to the
outgrowth of a small, activated population. Several ob-
servations support this conclusion. First, when purified
CD44loLy6C2 OT-I cells are transferred into irradiated
hosts, all of the cells upregulate CD44, Ly6C, and CD122
(Fig. 1), showing that truly naive T cells can undergo this
phenotypic conversion. Second, when CD44lo OT-I T
cells are labeled with CFSE before transfer, division is ob-
served in all of the transferred cells, and all of the cells di-
vide at a similar rate without evidence of a separate, rapidly
dividing subset (data not shown [11–13]). The reversion
from a “memory-like” to naive phenotype also appears to
be a property of the population as a whole. It is unlikely
that the reversion is due to the outgrowth of a small popu-
lation that did not convert accompanied by the massive
death of the “memory” phenotype OT-I cells, because the
reversion occurs at a time when the total number of OT-I
T cells is increasing only minimally, and very few cells in-
corporate BrdU (Figs. 2 and 3). For OT-I cell numbers to
be maintained in the absence of significant proliferation,
the majority must be reverting.
OT-I cells undergoing homeostasis-driven proliferation
are similar to antigen-experienced memory cells by the
phenotypic and functional assays we have used. Thus, a
“memory-like” phenotype can be acquired by CD81 T
cells in the absence of an encounter with cognate antigen.
This poses a real challenge for our ability to classify T cells,
as it implies that a significant number of antigen-inexperi-
enced T cells may be masquerading as memory cells as de-
fined by our current phenotypic and functional definitions.
This would be the case particularly for patients recovering
from treatment- or disease-induced lymphopenia. When T
cell populations from patients recovering from chemother-
apy or HIV-induced lymphopenia are analyzed, most of
the remaining T cells display an activated or memory phe-
notype (15, 16). The presence of these dividing memory
phenotype T cells has been used to argue that naive T cells
do not contribute to the restoration of the T cell compart-
ment during recovery from lymphopenia. In light of the
data presented in this paper and recently published by oth-
ers, it is reasonable to argue that some of the memory phe-
notype cells observed in lymphopenic patients may in fact
be residual naive T cells or recent thymic emigrants (11–
13, 21). Additionally, it is possible that homeostasis-driven
proliferation is ongoing at low levels in full lymphocyte
compartments, resulting in a population of “fake” memory
cells in normal hosts as well.
The most striking of our observations is that the CD81
T cells that acquire a “memory-like” phenotype during
homeostatic proliferation revert to a naive phenotype once
the T cell compartment is restored to normal numbers.
This implies that homeostasis-driven proliferation may pro-
vide a thymic-independent mechanism whereby naive T
cells can contribute to the reconstitution of the naive com-
Table I. Comparison of Homeostasis-driven Proliferation in B6 and RAG2/2 Hosts
Day 20 Day 68
Percentage
of BrdU* Cell no.‡
Percentage
of Lysis§
Percentage
of BrdU* Cell no.‡
Percentage
of Lysis§
OT-I RAG2/2®RAG2/2 54 3 30 35 9 66
OT-I RAG2/2®B6
36 46 43 7 83 7
Values represent average numbers from four mice per time point for irradiated B6 hosts, and two mice per time point for RAG2/2 hosts. In all, 10
RAG2/2 hosts were analyzed between days 12 and 92 after transfer.
*Percentage of BrdU1 cells out of Va21CD81 pooled spleen and lymph node cells.
‡Number of recovered Va21Vb51CD81 cells 31026.
§Specific lysis of OVAp-pulsed targets ex vivo at an E/T ratio of 100:1. The E/T ratio was normalized for the number of Va21Vb51CD81 cells,
and the lysis of targets without OVAp was ,6% for all samples.563 Goldrath et al.
partment after lymphopenia. In support of this notion, rat
T cells expressing low levels of CD45RC, typically consid-
ered to be memory cells, reexpress CD45RC after transfer
into nude hosts, thereby regaining their naive phenotype
(32, 33). Also, in experiments in which unseparated lymph
node cells were transferred into SCID mice, both naive and
memory T cell populations were observed 8 mo later (34).
Presumably, all of the cells initially divided and converted
to a memory phenotype in the empty lymphoid compart-
ment, implying that some of the cells reverted to generate a
pool of naive T cells.
We note that the change in surface phenotype and func-
tion correlates with cell division: when the cells are divid-
ing, they have a “memory-like” phenotype, and when
division ceases, the cells return to a naive phenotype.
Similarly, memory phenotype cells incorporate BrdU at
higher levels compared with naive phenotype cells (23). In
RAG2/2 hosts where the transferred cells continue to di-
vide indefinitely, the OT-I cells retain their “memory-
like” phenotype for .92 d (Fig. 6). The signal for the con-
version to a “memory-like” phenotype could be the signal
that drives the homeostatic proliferation itself, or cell divi-
sion may actually promote the changes. The fact that naive
T cells make IFN-g more slowly than memory or effector
cells may be explained by data showing that naive T cells
must undergo several rounds of division before they are
able to secrete IFN-g (35–37). Cell cycle progression is
thought to relieve epigenetic repression of gene expression,
possibly by causing changes in chromatin organization (35,
38). In memory and effector populations, the IFN-g locus
remains accessible because of the maintenance of a demeth-
ylated state (35, 37–39). It is provocative to consider that
the higher rate of division observed in the memory com-
partment in immunocompetent hosts could be responsible
for maintaining some of the phenotypic or functional char-
acteristics of memory cells via a cell cycle–dependent, epi-
genetic mechanism.
Why do cells undergoing homeostasis-driven prolifera-
tion convert to a “memory-like” phenotype? As discussed
above, the changes may simply be a side effect of cell divi-
sion. On the other hand, there may be a functional ratio-
nale for this conversion. One possibility is that the rapid re-
sponse characteristics of cells in a lymphopenic situation is
of benefit to the host when few T cells are available for de-
fense against pathogens. Another possibility is that the up-
regulation of signaling or adhesion molecules may be
important for controlling homeostatic proliferation. For
example, IL-15 is thought to maintain the homeostasis of
memory CD81 T cells, and in its absence the memory
compartment is disrupted (40, 41). IL-15 is also known to
be a strong promoter of proliferation for memory pheno-
type CD81 cells, and the upregulation of CD122, one of
the chains of the IL-15-receptor, could place the naive T
cells under the influence of IL-15 (42).
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